Neutral
Lyell Immunopharma: Q1 Earnings Snapshot
Lyell Immunopharma Inc. (LYEL) reported a first-quarter loss of $24.2 million, translating to $1.10 per share. The biotechnology company, based in Sou...
Lyell Immunopharma Inc. (LYEL) reported a first-quarter loss of $24.2 million, translating to $1.10 per share. The biotechnology company, based in Sou...